Product NDC: | 21695-159 |
Proprietary Name: | PAXIL |
Non Proprietary Name: | paroxetine hydrochloride |
Active Ingredient(s): | 12.5 mg/1 & nbsp; paroxetine hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 21695-159 |
Labeler Name: | Rebel Distributors Corp |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020936 |
Marketing Category: | NDA |
Start Marketing Date: | 20020409 |
Package NDC: | 21695-159-15 |
Package Description: | 15 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (21695-159-15) |
NDC Code | 21695-159-15 |
Proprietary Name | PAXIL |
Package Description | 15 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (21695-159-15) |
Product NDC | 21695-159 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | paroxetine hydrochloride |
Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20020409 |
Marketing Category Name | NDA |
Labeler Name | Rebel Distributors Corp |
Substance Name | PAROXETINE HYDROCHLORIDE |
Strength Number | 12.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |